K. Ono

CELL CYCLE REGULATION IN NORMAL VERSUS LEUKEMIC T CELLS

T. Sakai, Nikaido Toshio, K. Ono, 1994 .

Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.

K. Iida, N. Hiraiwa, A. Yoshiki, 2000, Cancer research.

A src family tyrosine kinase inhibits neurotransmitter release from neuronal cells

K. Ono, S. Kondo, M. Takahashi, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Localization of D-β-Aspartyl Residue-Containing Proteins in Various Tissues

S. Tsunoda, K. Nagata, K. Ono, 2009, International journal of molecular sciences.

Ubiquitin-dependent degradation of I_B_ is mediated by a′ ubiquitin ligase Skp1/Cul 1/F-box protein FWD1.

M. Kitagawa, K. Ono, H. Nakano, 1999 .

Depletion of RUVBL2 in Human Cells Confers Moderate Sensitivity to Anticancer Agents

K. Ono, H. Ide, A. Salem, 2014 .

Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.

T. Sakai, N. Ohtani‐Fujita, K. Ono, 1994, Experimental cell research.

Characterization of zetin 1/rBSPRY, a novel binding partner of 14-3-3 proteins.

K. Ono, H. Betz, B. Anliker, 2003, Biochemical and biophysical research communications.

Intronic Enhancer Is Essential for Nr5a1 Expression in the Pituitary Gonadotrope and for Postnatal Development of Male Reproductive Organs in a Mouse Model

K. Ono, K. Toida, H. Tsukamura, 2022, International journal of molecular sciences.